Historical Perspective and Current Trends in Anticancer Drug Development

Katarzyna Gach-Janczak,Joanna Drogosz-Stachowicz,Anna Janecka,Karol Wtorek,Marek Mirowski

DOI: https://doi.org/10.3390/cancers16101878

2024-05-16

Cancers

Abstract:Cancer is considered one of the leading causes of death in the 21st century. The intensive search for new anticancer drugs has been actively pursued by chemists and pharmacologists for decades, focusing either on the isolation of compounds with cytotoxic properties from plants or on screening thousands of synthetic molecules. Compounds that could potentially become candidates for new anticancer drugs must have the ability to inhibit proliferation and/or induce apoptosis in cancer cells without causing too much damage to normal cells. Some anticancer compounds were discovered by accident, others as a result of long-term research. In this review, we have presented a brief history of the development of the most important groups of anticancer drugs, pointing to the fact that they all have many side effects.

oncology

What problem does this paper attempt to address?

The paper primarily explores the development history and current trends of anti-cancer drugs. The author first outlines the current status of cancer as one of the leading causes of death globally and emphasizes that chemotherapy remains one of the most commonly used methods for treating cancer. Subsequently, the paper reviews the historical development of several key stages:

1. **The Beginning of Chemotherapy**: Originating in the 19th century with the study of substances with anti-cancer activity in plants, such as podophyllotoxin extracted from the root of Podophyllum peltatum, which can inhibit cell division. Based on this discovery, two analogs—etoposide and teniposide—were later synthesized, and these drugs are still in clinical use today.

2. **Mustard Gas and Its Derivatives**: After World War I, researchers observed that mustard gas (a chemical warfare agent) could significantly reduce white blood cell counts. This inspired scientists to develop less toxic derivatives, such as cyclophosphamide, chlorambucil, ifosfamide, and melphalan, which are now used in cancer treatment.

3. **Folate Antagonists**: Research found that folic acid is crucial for bone marrow function. Dr. Sidney Farber noticed that folic acid could promote the growth of leukemia cells, leading him to hypothesize that folic acid antagonists might inhibit or stop the proliferation of cancer cells. This theory led to the development of drugs like methotrexate, which indirectly inhibit cell division by blocking enzymes related to folic acid.

4. **Antimetabolites**: In the mid-1950s, 5-fluorouracil (5-FU) was discovered to be effective against various solid tumors. Its mechanisms of action include interfering with RNA and DNA synthesis and inhibiting thymidylate synthase.

5. **Anticancer Antibiotics**: Examples include mitomycin C and anthracycline antibiotics (such as doxorubicin and daunorubicin), which exert their anti-tumor effects by disrupting DNA structure through different mechanisms. Although these drugs are highly effective, they also come with severe side effects.

In summary, this review paper aims to introduce the major development history, mechanisms of action, and future research directions of anti-cancer drugs, while also pointing out the limitations and potential adverse effects of existing drugs.